GloGlo
New accelerator entry · 2023-11-24 · the record
In their words
Our mission: eradicate type 1 diabetes. GloGlo is building an AI-native therapeutics company focused on accelerating the discovery of treatments that can prevent, stop, and ultimately cure type 1 diabetes. We are developing AI research agents that continuously analyze scientific literature and biological datasets, generate and challenge hypotheses, design experiments, and run them in a wet lab to learn from experimental results. We are building a tight "in silico <> in vitro/vivo" feedback loop that helps us identify better targets, run experiments more efficiently, and move faster toward therapies for type 1 diabetes.
What the record says
The full profile
Source Check, INVEST, RECRUIT and Press Requests on GloGlo
- Source Check — verify what GloGlo states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with GloGlo for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist GloGloYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind GloGlo: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.